Odonate Therapeutics (ODTC)
Odonate, Inc. is a common stock listing on OTC Markets for a healthcare-sector issuer that currently has no significant operations. The company was originally founded in 2013 under the name Odonate Therapeutics, Inc. and adopted its current name in March 2023. It is based in New York, New York. The available description indicates a limited operating profile, so the listing is best viewed in the context of the corporate shell rather than an active pharmaceutical business.
Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ
Jump directly to the stock analysis sections supported by the latest available data.
Data update note:
Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Market Cap |
|---|---|---|---|---|---|---|
|
OTC-ODTC
|
Not available
|
Not available
|
Not available
|
Good
|
0.0%
|
53.25 M
|
